相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tumor Origins Through Genomic Profiles
Edison T. Liu et al.
JAMA ONCOLOGY (2020)
Clinical and Molecular Correlates of Tumor Mutation Burden in Non-Small Cell Lung Cancer
Michael F. Sharpnack et al.
LUNG CANCER (2020)
The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee
Lynette Sholl et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
First-Line Nivolumab Plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers
Neal Ready et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Current views on tumor mutational burden in patients with non-small cell lung cancer treated by immune checkpoint inhibitors
Lea Berland et al.
JOURNAL OF THORACIC DISEASE (2019)
Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer
Biagio Ricciuti et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Next generation sequencing-based gene panel tests for the management of solid tumors
Masayuki Nagahashi et al.
CANCER SCIENCE (2019)
Implementing TMB measurement in clinical practice: considerations on assay requirements
Reinhard Buettner et al.
ESMO OPEN (2019)
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sanchez-Vega et al.
CELL (2018)
Common driver mutations and smoking history affect tumor mutation burden in lung adenocarcinoma
Masayuki Nagahashi et al.
JOURNAL OF SURGICAL RESEARCH (2018)
Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab
David R. Gandara et al.
NATURE MEDICINE (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
Tumor mutational burden assessment as a predictive biomarker for immunotherapy in lung cancer patients: getting ready for prime-time or not?
Simon Heeke et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2018)
Validation of OncoPanel A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer
Elizabeth P. Garcia et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2017)
Association of tumor mutational burden with smoking and mutation status in non-small cell lung cancer (NSCLC).
Andrew A. Davis et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Five-Year Survival in EGFR-Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIs
Jessica J. Lin et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Lung cancer mutation profile of EGFR, ALK, and KRAS: Meta-analysis and comparison of never and ever smokers
Aaron M. Chapman et al.
LUNG CANCER (2016)
Mutational signatures associated with tobacco smoking in human cancer
Ludmil B. Alexandrov et al.
SCIENCE (2016)
f Institutional implementation of clinical tumor profiling on an unselected cancer population
Lynette M. Sholl et al.
JCI INSIGHT (2016)
Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers
Ramaswamy Govindan et al.
CELL (2012)
Molecular Epidemiology of EGFR and KRAS Mutations in 3,026 Lung Adenocarcinomas: Higher Susceptibility of Women to Smoking-Related KRAS-Mutant Cancers
Snjezana Dogan et al.
CLINICAL CANCER RESEARCH (2012)
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
Li Ding et al.
NATURE (2012)
Evolving Concepts in Lung Carcinogenesis
Brigitte N. Gomperts et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
The mutation spectrum revealed by paired genome sequences from a lung cancer patient
William Lee et al.
NATURE (2010)
Modeling lung cancer risk in case-control studies using a new dose metric of smoking
SW Thurston et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke:: Distinct patterns in never, former, and current smokers
F Le Calvez et al.
CANCER RESEARCH (2005)
分享论文
